3Kawaguchi Y.Peritoneal dialysis as long-term treatment:Comparison of technique survival between Asian and Western populations.Perit Dial Int,1999,19(Suppl 2):S327-S328.
4Mactier RA,Khanna R.Effect of peritonitis on insulin and glucose absorption during peritoneal dialysis in diabetic rats.Nephron,1990,54(3):240-244.
5Pelin K,Kirvonen A,Linnainmaa K.Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells.Carcinogenesis,1994,15 (11):2673-2675.
6Zeillemaker AM,Mul FP,Van Papendrecht AA,et al.Limited influence of the mesothelium on the influx of monocytes into the peritoneal cavity.Inflammation,1996,20(1):87-95.
7Zeillemaker AM,Verbrugh HA,Hoynck van Papendrecht AA,et al.CA 125 secretion by peritoneal mesothelial cells.J Clin Pathol,1994,47(3):263-265.
8Heldin P,Suzuki M,Teder P,et al.Chondroitin sulfate pro teoglycan modulates the permeability of hyaluronan-conraining coats around normal human mesothelial cells.J Cell Physiol,1995,165(1):54-61.
9Yung S,Coles GA,Williams JD,et al.The source and possible significance of hyaluronan in the peritoneal cavity.Kidney Int,1994,46(2):527-533.
10Marshall BC,Santana A,Xu QP,et al.Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells.Cellular differentiation influences expression.J Clin Invest,1993,91(4):1792-1799.
